150 related articles for article (PubMed ID: 36512632)
1. CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer.
Zou S; Qin B; Yang Z; Wang W; Zhang J; Zhang Y; Meng M; Feng J; Xie Y; Fang L; Xiao L; Zhang P; Meng X; Choi HH; Wen W; Pan Q; Ghesquière B; Lan P; Lee MH; Fang L
Cancer Res; 2023 Feb; 83(3):414-427. PubMed ID: 36512632
[TBL] [Abstract][Full Text] [Related]
2. COP9 signalosome subunit 6 mediates PDGF -induced pulmonary arterial smooth muscle cells proliferation.
Zhu Y; Li F; Shi W; Zhai C; Wang J; Yan X; Wang Q; Zhang Q; Yang L; Gao L; Li M
Exp Cell Res; 2018 Oct; 371(2):379-388. PubMed ID: 30180991
[TBL] [Abstract][Full Text] [Related]
3. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
[TBL] [Abstract][Full Text] [Related]
4. CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis.
Qin B; Zou S; Li K; Wang H; Wei W; Zhang B; Xiao L; Choi HH; Tang Q; Huang D; Liu Q; Pan Q; Meng M; Fang L; Lee MH
Br J Cancer; 2020 May; 122(11):1673-1685. PubMed ID: 32225170
[TBL] [Abstract][Full Text] [Related]
5. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
6. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
Mei ZL; Wang HB; Hu YH; Xiong L
Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
[TBL] [Abstract][Full Text] [Related]
7. CSN6, a subunit of the COP9 signalosome, is involved in early response to iron deficiency in Oryza sativa.
Tan S; Liu F; Pan XX; Zang YP; Jin F; Zu WX; Qi XT; Xiao W; Yin LP
Sci Rep; 2016 May; 6():25485. PubMed ID: 27137867
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of CSN6 expression in upper tract urothelial carcinomas.
Jhan JH; Lee YC; Li WM; Chang LL; Hsu WC; Lin HH; Liang PI; Hsu YL; Wu WJ; Lee HY; Li CC; Yeh HC; Ke HL
Kaohsiung J Med Sci; 2019 Sep; 35(9):559-565. PubMed ID: 31339657
[TBL] [Abstract][Full Text] [Related]
9. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.
Zhao R; Yeung SC; Chen J; Iwakuma T; Su CH; Chen B; Qu C; Zhang F; Chen YT; Lin YL; Lee DF; Jin F; Zhu R; Shaikenov T; Sarbassov D; Sahin A; Wang H; Wang H; Lai CC; Tsai FJ; Lozano G; Lee MH
J Clin Invest; 2011 Mar; 121(3):851-65. PubMed ID: 21317535
[TBL] [Abstract][Full Text] [Related]
10. CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.
Mou J; Wei L; Liang J; Du W; Pei D
Int J Med Sci; 2020; 17(17):2809-2818. PubMed ID: 33162808
[No Abstract] [Full Text] [Related]
11. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development.
Fang L; Lu W; Choi HH; Yeung SC; Tung JY; Hsiao CD; Fuentes-Mattei E; Menter D; Chen C; Wang L; Wang J; Lee MH
Cancer Cell; 2015 Aug; 28(2):183-97. PubMed ID: 26267535
[TBL] [Abstract][Full Text] [Related]
12. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
13. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
Gao WY; Yang G; Wang J; He JM; Wang P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
[TBL] [Abstract][Full Text] [Related]
14. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
[TBL] [Abstract][Full Text] [Related]
15. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.
Mao Z; Chen C; Pei DS
Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513
[TBL] [Abstract][Full Text] [Related]
17. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.
Chen B; Zhao R; Su CH; Linan M; Tseng C; Phan L; Fang L; Yang HY; Yang H; Wang W; Xu X; Jiang N; Cai S; Jin F; Yeung SC; Lee MH
Cell Cycle; 2012 Dec; 11(24):4633-41. PubMed ID: 23187808
[TBL] [Abstract][Full Text] [Related]
18. CSN6: a promising target for cancer prevention and therapy.
Hou J; Cui H
Histol Histopathol; 2020 Jul; 35(7):645-652. PubMed ID: 32016946
[TBL] [Abstract][Full Text] [Related]
19. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.
Wei W; Qin B; Wen W; Zhang B; Luo H; Wang Y; Xu H; Xie X; Liu S; Jiang X; Wang M; Tang Q; Zhang J; Yang R; Fan Z; Lyu H; Lin J; Li K; Lee MH
Signal Transduct Target Ther; 2023 May; 8(1):187. PubMed ID: 37202390
[TBL] [Abstract][Full Text] [Related]
20. CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.
Shi J; Guan X; Zhan F; Liu C; Li Z; Yao Y; Wang B; Lou C; Zhang Y
Cancer Biol Ther; 2019; 20(9):1290-1299. PubMed ID: 31311398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
